22,135,656
Vote Records
28,570
Companies
12,092
Funds
3,981
Managers

Home › Companies › AMGEN INC. › 2024-2025

AMGEN INC. 2024-2025 Proxy Voting Records

Download data (CSV): ballot items · votes by manager · column guide.

Compiled from SEC Form N-PX filings and AMGEN INC.’s Form 8-K, filed May 27, 2025 (Item 5.07 on EDGAR). Page generated November 20, 2026.

  • 14Ballot items
  • 1,504Asset managers, any item
  • 18,076Fund votes
  • May 23, 2025Meeting date

Results at a glance

Meeting of May 23, 2025: 14 items on AMGEN INC.’s Form 8-K, filed May 27, 2025: 12 elected · 2 approved.

Dissent

No notable dissent.

Dissent tiers, on the company’s own Form 8-K tally (support = FOR ÷ (FOR + AGAINST), or FOR ÷ (FOR + WITHHELD) on a withhold ballot; abstentions and broker non-votes excluded): shareholder proposals with 15% support or more are notable, 25% significant, 40% high; director nominees with 10% or more against or withheld are notable, 20% significant; say-on-pay under 80% support is notable, under 70% significant; equity and compensation plans with 15% or more against are notable, 25% significant; any other item the board put forward with 15% or more against is notable. How this is decided

Proxy season: 2023-2024 2024-2025 2025-2026

Explore AMGEN INC. in the interactive database Compare manager voting policies

Official 2024-2025 meeting results reported by AMGEN INC.

These tallies are AMGEN INC.’s own, as disclosed to the U.S. Securities and Exchange Commission on Form 8-K, filed May 27, 2025 (Item 5.07, “Submission of Matters to a Vote of Security Holders”). They cover every share voted at the meeting, not just the funds that file Form N-PX.

AMGEN INC. — official shareholder meeting results, meeting held May 23, 2025
Ballot itemForAgainst AbstainWithheldBroker non-votesSupport (of votes cast)Reported outcomeVoting standard
Elect Director: Dr. Wanda M. Austin 399,241,1844,695,034624,456 --64,590,100 99%Elected—
Elect Director: Mr. Robert A. Bradway 375,676,87226,441,7852,442,017 --64,590,100 93%Elected—
Elect Director: Dr. Michael V. Drake 399,379,2124,268,118913,344 --64,590,100 99%Elected—
Elect Director: Dr. Brian J. Druker 399,421,4754,481,785657,414 --64,590,100 99%Elected—
Elect Director: Mr. Robert A. Eckert 381,713,09721,605,9571,241,620 --64,590,100 95%Elected—
Elect Director: Mr. Greg C. Garland 384,198,58319,699,619662,472 --64,590,100 95%Elected—
Elect Director: Mr. Charles M. Holley, Jr. 396,883,0707,000,392677,212 --64,590,100 98%Elected—
Elect Director: Dr. S. Omar Ishrak 398,671,8215,218,699670,154 --64,590,100 99%Elected—
Elect Director: Dr. Tyler Jacks 392,818,61610,591,0221,151,036 --64,590,100 97%Elected—
Elect Director: Dr. Mary E. Klotman 400,133,2523,547,127880,295 --64,590,100 99.1%Elected—
Elect Director: Ms. Ellen J. Kullman 399,256,8574,429,859873,958 --64,590,100 99%Elected—
Elect Director: Ms. Amy E. Miles 399,556,3514,116,751887,572 --64,590,100 99%Elected—
2. Advisor y Vote to A pprove Our Executive Compensation The advisory vote to approve our executive compensation 381,269,28121,382,0501,909,343 --64,590,100 95%Approved—
3. Ratification of Selection of Inde pendent Re gistered Public Accountants Ernst & Young LLP 441,615,58126,675,877859,316 ---- 94%Approved—

Source: AMGEN INC., Form 8-K, filed with the SEC on May 27, 2025 — read the filing on EDGAR.

How asset managers voted at the AMGEN INC. 2024-2025 meeting

1,504 asset managers disclosed a vote on at least one AMGEN INC. item in their SEC Form N-PX filings. Each item below shows how many of them voted on it, and how. Share totals are the shares those managers' funds voted, summed across every fund they report.

Elect Director: Dr. Wanda M. Austin

Official resultDIRECTOR ELECTIONSReported outcome: Elected

Combines 10 wordings of this item as funds reported it.

99% Majority: yes · of votes cast

FOR 99%
FOR: 399,241,184AGAINST: 4,695,034

Prior year: 98.9% for (May 31, 2024 meeting) ▼ 0.1 pts

Details: description as filed, official tally, votes by 230 asset managers

Description as filed by funds: To elect twelve directors to the Board of Directors of Amgen Inc. for a term of office expiring at the 2026 annual meeting of stockholders. The nominees for election to the Board of Directors are: Dr. Wanda M. Austin

AMGEN INC.’s own tally for this item (“Elect Director: Dr. Wanda M. Austin”): 399,241,184 for, 4,695,034 against, per its Form 8-K filed May 27, 2025 (Item 5.07). FOR was more than half of the votes cast. Whether the item passed is for the filing to say; its statement has not been read for this item.

Reported outcome: Elected, in the filing’s own words: “The final results of the voting for each matter submitted to a vote of stockholders at the meeting are as follows: Item 1 - Election of Directors Each of the following 12 nominees for director were elected to serve a one-year term expiring at the Company's 2026 annual meeting of stockholders and un…”
Support: 99% of votes cast — FOR ÷ (FOR + AGAINST); abstentions and broker non-votes are excluded.

The 230 asset managers below reported 178,903,817 for, 403,590 against, 27,734 abstained, 2,512 unknown.

FOR
FOR: 178,903,817AGAINST: 403,590ABSTAIN: 27,734UNKNOWN: 2,512
Largest asset managers voting on “To elect twelve directors to the Board of Directors of Amgen Inc. for a term of office expiring at the 2026 an” at AMGEN INC., 2024-2025
Asset managerForAgainst AbstainWithheldVote
Vanguard62,786,1306 10For
Capital Group33,518,1140 00For
BlackRock16,504,7890 00For
Fidelity13,803,2470 00For
Charles Schwab12,079,4430 00For
State Street5,952,4930 00For
Dimensional2,336,6420 00For
Franklin Custodian Funds2,053,7860 00For
TIAA1,833,2440 00For
Pacer Funds Trust1,570,9570 00For
JANUS INVESTMENT FUND1,389,6680 00For
Federated Hermes1,324,1540 00For
T. Rowe Price1,117,4570 00For
AMCAP FUND1,106,8840 00For
Jackson National1,105,9050 00For
Victory Capital1,039,5690 00For
INVESTMENT CO OF AMERICA990,2820 00For
ProShares980,7770 00For
Smead Funds Trust906,8630 00For
Invesco882,7380 00For
VanEck ETF Trust882,5070 00For
MASTER INVESTMENT PORTFOLIO774,6200 00For
CITY NATIONAL ROCHDALE FUNDS699,2800 00For
PRIMECAP Odyssey Funds618,1800 00For
Equitable609,9910 00For

Showing the 25 largest of 230 asset managers. All 230 are in the interactive database (link above).

Elect Director: Mr. Robert A. Bradway

Official resultDIRECTOR ELECTIONSReported outcome: Elected

Combines 12 wordings of this item as funds reported it.

93% Majority: yes · of votes cast

FOR 93%
FOR: 375,676,872AGAINST: 26,441,785

Prior year: 93.8% for (May 31, 2024 meeting) ▼ 0.3 pts

Details: description as filed, official tally, votes by 230 asset managers

Description as filed by funds: To elect twelve directors to the Board of Directors of Amgen Inc. for a term of office expiring at the 2026 annual meeting of stockholders. The nominees for election to the Board of Directors are: Mr. Robert A. Bradway

AMGEN INC.’s own tally for this item (“Elect Director: Mr. Robert A. Bradway”): 375,676,872 for, 26,441,785 against, per its Form 8-K filed May 27, 2025 (Item 5.07). FOR was more than half of the votes cast. Whether the item passed is for the filing to say; its statement has not been read for this item.

Reported outcome: Elected, in the filing’s own words: “The final results of the voting for each matter submitted to a vote of stockholders at the meeting are as follows: Item 1 - Election of Directors Each of the following 12 nominees for director were elected to serve a one-year term expiring at the Company's 2026 annual meeting of stockholders and un…”
Support: 93% of votes cast — FOR ÷ (FOR + AGAINST); abstentions and broker non-votes are excluded.

The 230 asset managers below reported 179,101,067 for, 207,586 against, 27,737 abstained, 1,263 unknown.

FOR
FOR: 179,101,067AGAINST: 207,586ABSTAIN: 27,737UNKNOWN: 1,263
Largest asset managers voting on “To elect twelve directors to the Board of Directors of Amgen Inc. for a term of office expiring at the 2026 an” at AMGEN INC., 2024-2025
Asset managerForAgainst AbstainWithheldVote
Vanguard62,786,09244 10For
Capital Group33,518,1140 00For
BlackRock16,504,7890 00For
Fidelity13,803,2470 00For
Charles Schwab12,079,4430 00For
State Street5,952,46033 00For
Dimensional2,336,6420 00For
Franklin Custodian Funds2,053,7860 00For
TIAA1,833,2440 00For
Pacer Funds Trust1,570,9570 00For
JANUS INVESTMENT FUND1,389,6680 00For
Federated Hermes1,324,1540 00For
T. Rowe Price1,117,4570 00For
AMCAP FUND1,106,8840 00For
Jackson National1,105,9050 00For
Victory Capital1,039,5690 00For
INVESTMENT CO OF AMERICA990,2820 00For
ProShares980,7770 00For
Smead Funds Trust906,8630 00For
Invesco882,7380 00For
VanEck ETF Trust882,5070 00For
MASTER INVESTMENT PORTFOLIO774,6200 00For
CITY NATIONAL ROCHDALE FUNDS699,2800 00For
PRIMECAP Odyssey Funds618,1800 00For
Equitable609,9910 00For

Showing the 25 largest of 230 asset managers. All 230 are in the interactive database (link above).

Elect Director: Dr. Michael V. Drake

Official resultDIRECTOR ELECTIONSReported outcome: Elected

Combines 12 wordings of this item as funds reported it.

99% Majority: yes · of votes cast

FOR 99%
FOR: 399,379,212AGAINST: 4,268,118

Prior year: 98.3% for (May 31, 2024 meeting) ▲ 0.6 pts

Details: description as filed, official tally, votes by 230 asset managers

Description as filed by funds: To elect twelve directors to the Board of Directors of Amgen Inc. for a term of office expiring at the 2026 annual meeting of stockholders. The nominees for election to the Board of Directors are: Dr. Michael V. Drake

AMGEN INC.’s own tally for this item (“Elect Director: Dr. Michael V. Drake”): 399,379,212 for, 4,268,118 against, per its Form 8-K filed May 27, 2025 (Item 5.07). FOR was more than half of the votes cast. Whether the item passed is for the filing to say; its statement has not been read for this item.

Reported outcome: Elected, in the filing’s own words: “The final results of the voting for each matter submitted to a vote of stockholders at the meeting are as follows: Item 1 - Election of Directors Each of the following 12 nominees for director were elected to serve a one-year term expiring at the Company's 2026 annual meeting of stockholders and un…”
Support: 99% of votes cast — FOR ÷ (FOR + AGAINST); abstentions and broker non-votes are excluded.

The 230 asset managers below reported 179,039,612 for, 256,963 against, 40,076 abstained, 1,002 unknown.

FOR
FOR: 179,039,612AGAINST: 256,963ABSTAIN: 40,076UNKNOWN: 1,002
Largest asset managers voting on “To elect twelve directors to the Board of Directors of Amgen Inc. for a term of office expiring at the 2026 an” at AMGEN INC., 2024-2025
Asset managerForAgainst AbstainWithheldVote
Vanguard62,786,1287 20For
Capital Group33,518,1140 00For
BlackRock16,501,2483,541 00For
Fidelity13,803,2470 00For
Charles Schwab12,079,4430 00For
State Street5,952,4930 00For
Dimensional2,336,6420 00For
Franklin Custodian Funds2,053,7860 00For
TIAA1,833,2440 00For
Pacer Funds Trust1,570,9570 00For
JANUS INVESTMENT FUND1,389,6680 00For
Federated Hermes1,324,1540 00For
T. Rowe Price1,117,4570 00For
AMCAP FUND1,106,8840 00For
Jackson National1,105,9050 00For
Victory Capital1,039,5690 00For
INVESTMENT CO OF AMERICA990,2820 00For
ProShares980,7770 00For
Smead Funds Trust906,8630 00For
Invesco882,7380 00For
VanEck ETF Trust882,5070 00For
MASTER INVESTMENT PORTFOLIO774,6200 00For
CITY NATIONAL ROCHDALE FUNDS699,2800 00For
PRIMECAP Odyssey Funds618,1800 00For
Equitable609,9910 00For

Showing the 25 largest of 230 asset managers. All 230 are in the interactive database (link above).

Elect Director: Dr. Brian J. Druker

Official resultDIRECTOR ELECTIONSReported outcome: Elected

Combines 11 wordings of this item as funds reported it.

99% Majority: yes · of votes cast

FOR 99%
FOR: 399,421,475AGAINST: 4,481,785

Prior year: 99.2% for (May 31, 2024 meeting) ▼ 0.3 pts

Details: description as filed, official tally, votes by 230 asset managers

Description as filed by funds: To elect twelve directors to the Board of Directors of Amgen Inc. for a term of office expiring at the 2026 annual meeting of stockholders. The nominees for election to the Board of Directors are: Dr. Brian J. Druker

AMGEN INC.’s own tally for this item (“Elect Director: Dr. Brian J. Druker”): 399,421,475 for, 4,481,785 against, per its Form 8-K filed May 27, 2025 (Item 5.07). FOR was more than half of the votes cast. Whether the item passed is for the filing to say; its statement has not been read for this item.

Reported outcome: Elected, in the filing’s own words: “The final results of the voting for each matter submitted to a vote of stockholders at the meeting are as follows: Item 1 - Election of Directors Each of the following 12 nominees for director were elected to serve a one-year term expiring at the Company's 2026 annual meeting of stockholders and un…”
Support: 99% of votes cast — FOR ÷ (FOR + AGAINST); abstentions and broker non-votes are excluded.

The 230 asset managers below reported 178,900,154 for, 407,250 against, 27,736 abstained, 2,512 unknown.

FOR
FOR: 178,900,154AGAINST: 407,250ABSTAIN: 27,736UNKNOWN: 2,512
Largest asset managers voting on “To elect twelve directors to the Board of Directors of Amgen Inc. for a term of office expiring at the 2026 an” at AMGEN INC., 2024-2025
Asset managerForAgainst AbstainWithheldVote
Vanguard62,786,1306 10For
Capital Group33,518,1140 00For
BlackRock16,501,2483,541 00For
Fidelity13,803,2470 00For
Charles Schwab12,079,4430 00For
State Street5,952,4930 00For
Dimensional2,336,6420 00For
Franklin Custodian Funds2,053,7860 00For
TIAA1,833,2440 00For
Pacer Funds Trust1,570,9570 00For
JANUS INVESTMENT FUND1,389,6680 00For
Federated Hermes1,324,1540 00For
T. Rowe Price1,117,4570 00For
AMCAP FUND1,106,8840 00For
Jackson National1,105,9050 00For
Victory Capital1,039,5690 00For
INVESTMENT CO OF AMERICA990,2820 00For
ProShares980,7770 00For
Smead Funds Trust906,8630 00For
Invesco882,7380 00For
VanEck ETF Trust882,5070 00For
MASTER INVESTMENT PORTFOLIO774,6200 00For
CITY NATIONAL ROCHDALE FUNDS699,2800 00For
PRIMECAP Odyssey Funds618,1800 00For
Equitable609,9910 00For

Showing the 25 largest of 230 asset managers. All 230 are in the interactive database (link above).

Elect Director: Mr. Robert A. Eckert

Official resultDIRECTOR ELECTIONSReported outcome: Elected

Combines 12 wordings of this item as funds reported it.

95% Majority: yes · of votes cast

FOR 95%
FOR: 381,713,097AGAINST: 21,605,957

Prior year: 94.7% for (May 31, 2024 meeting) ▼ 0.1 pts

Details: description as filed, official tally, votes by 230 asset managers

Description as filed by funds: To elect twelve directors to the Board of Directors of Amgen Inc. for a term of office expiring at the 2026 annual meeting of stockholders. The nominees for election to the Board of Directors are: Mr. Robert A. Eckert

AMGEN INC.’s own tally for this item (“Elect Director: Mr. Robert A. Eckert”): 381,713,097 for, 21,605,957 against, per its Form 8-K filed May 27, 2025 (Item 5.07). FOR was more than half of the votes cast. Whether the item passed is for the filing to say; its statement has not been read for this item.

Reported outcome: Elected, in the filing’s own words: “The final results of the voting for each matter submitted to a vote of stockholders at the meeting are as follows: Item 1 - Election of Directors Each of the following 12 nominees for director were elected to serve a one-year term expiring at the Company's 2026 annual meeting of stockholders and un…”
Support: 95% of votes cast — FOR ÷ (FOR + AGAINST); abstentions and broker non-votes are excluded.

The 230 asset managers below reported 178,309,234 for, 998,129 against, 27,778 abstained, 2,512 unknown.

FOR
FOR: 178,309,234AGAINST: 998,129ABSTAIN: 27,778UNKNOWN: 2,512
Largest asset managers voting on “To elect twelve directors to the Board of Directors of Amgen Inc. for a term of office expiring at the 2026 an” at AMGEN INC., 2024-2025
Asset managerForAgainst AbstainWithheldVote
Vanguard62,766,84119,294 20For
Capital Group33,518,1140 00For
BlackRock16,501,2483,541 00For
Fidelity13,803,2470 00For
Charles Schwab12,079,4430 00For
State Street5,952,39895 00For
Dimensional2,336,6420 00For
Franklin Custodian Funds2,053,7860 00For
TIAA1,833,2440 00For
Pacer Funds Trust1,570,9570 00For
JANUS INVESTMENT FUND1,389,6680 00For
Federated Hermes1,324,1540 00For
T. Rowe Price1,117,4570 00For
AMCAP FUND1,106,8840 00For
Jackson National1,105,9050 00For
Victory Capital1,039,5690 00For
INVESTMENT CO OF AMERICA990,2820 00For
ProShares980,7770 00For
Smead Funds Trust906,8630 00For
Invesco882,7380 00For
VanEck ETF Trust882,5070 00For
MASTER INVESTMENT PORTFOLIO774,6200 00For
CITY NATIONAL ROCHDALE FUNDS699,2800 00For
PRIMECAP Odyssey Funds618,1800 00For
Equitable609,9910 00For

Showing the 25 largest of 230 asset managers. All 230 are in the interactive database (link above).

Elect Director: Mr. Greg C. Garland

Official resultDIRECTOR ELECTIONSReported outcome: Elected

Combines 11 wordings of this item as funds reported it.

95% Majority: yes · of votes cast

FOR 95%
FOR: 384,198,583AGAINST: 19,699,619

Prior year: 96.9% for (May 31, 2024 meeting) ▼ 1.8 pts

Details: description as filed, official tally, votes by 230 asset managers

Description as filed by funds: To elect twelve directors to the Board of Directors of Amgen Inc. for a term of office expiring at the 2026 annual meeting of stockholders. The nominees for election to the Board of Directors are: Mr. Greg C. Garland

AMGEN INC.’s own tally for this item (“Elect Director: Mr. Greg C. Garland”): 384,198,583 for, 19,699,619 against, per its Form 8-K filed May 27, 2025 (Item 5.07). FOR was more than half of the votes cast. Whether the item passed is for the filing to say; its statement has not been read for this item.

Reported outcome: Elected, in the filing’s own words: “The final results of the voting for each matter submitted to a vote of stockholders at the meeting are as follows: Item 1 - Election of Directors Each of the following 12 nominees for director were elected to serve a one-year term expiring at the Company's 2026 annual meeting of stockholders and un…”
Support: 95% of votes cast — FOR ÷ (FOR + AGAINST); abstentions and broker non-votes are excluded.

The 230 asset managers below reported 178,408,822 for, 898,583 against, 27,737 abstained, 2,512 unknown.

FOR
FOR: 178,408,822AGAINST: 898,583ABSTAIN: 27,737UNKNOWN: 2,512
Largest asset managers voting on “To elect twelve directors to the Board of Directors of Amgen Inc. for a term of office expiring at the 2026 an” at AMGEN INC., 2024-2025
Asset managerForAgainst AbstainWithheldVote
Vanguard62,786,10630 10For
Capital Group33,518,1140 00For
BlackRock16,504,7890 00For
Fidelity13,803,2470 00For
Charles Schwab12,079,4430 00For
State Street5,952,39895 00For
Dimensional2,336,6420 00For
Franklin Custodian Funds2,053,7860 00For
TIAA1,833,2440 00For
Pacer Funds Trust1,570,9570 00For
JANUS INVESTMENT FUND1,389,6680 00For
Federated Hermes1,324,1540 00For
T. Rowe Price1,117,4570 00For
AMCAP FUND1,106,8840 00For
Jackson National1,105,9050 00For
Victory Capital1,039,5690 00For
INVESTMENT CO OF AMERICA990,2820 00For
ProShares980,7770 00For
Smead Funds Trust906,8630 00For
Invesco882,7380 00For
VanEck ETF Trust882,5070 00For
MASTER INVESTMENT PORTFOLIO774,6200 00For
CITY NATIONAL ROCHDALE FUNDS699,2800 00For
PRIMECAP Odyssey Funds618,1800 00For
Equitable609,9910 00For

Showing the 25 largest of 230 asset managers. All 230 are in the interactive database (link above).

Elect Director: Mr. Charles M. Holley, Jr.

Official resultDIRECTOR ELECTIONSReported outcome: Elected

Combines 12 wordings of this item as funds reported it.

98% Majority: yes · of votes cast

FOR 98%
FOR: 396,883,070AGAINST: 7,000,392

Prior year: 96.4% for (May 31, 2024 meeting) ▲ 1.9 pts

Details: description as filed, official tally, votes by 230 asset managers

Description as filed by funds: To elect twelve directors to the Board of Directors of Amgen Inc. for a term of office expiring at the 2026 annual meeting of stockholders. The nominees for election to the Board of Directors are: Mr. Charles M. Holley, Jr.

AMGEN INC.’s own tally for this item (“Elect Director: Mr. Charles M. Holley, Jr.”): 396,883,070 for, 7,000,392 against, per its Form 8-K filed May 27, 2025 (Item 5.07). FOR was more than half of the votes cast. Whether the item passed is for the filing to say; its statement has not been read for this item.

Reported outcome: Elected, in the filing’s own words: “The final results of the voting for each matter submitted to a vote of stockholders at the meeting are as follows: Item 1 - Election of Directors Each of the following 12 nominees for director were elected to serve a one-year term expiring at the Company's 2026 annual meeting of stockholders and un…”
Support: 98% of votes cast — FOR ÷ (FOR + AGAINST); abstentions and broker non-votes are excluded.

The 230 asset managers below reported 179,041,424 for, 267,490 against, 27,738 abstained, 1,002 unknown.

FOR
FOR: 179,041,424AGAINST: 267,490ABSTAIN: 27,738UNKNOWN: 1,002
Largest asset managers voting on “To elect twelve directors to the Board of Directors of Amgen Inc. for a term of office expiring at the 2026 an” at AMGEN INC., 2024-2025
Asset managerForAgainst AbstainWithheldVote
Vanguard62,786,12412 10For
Capital Group33,518,1140 00For
BlackRock16,504,7890 00For
Fidelity13,803,2470 00For
Charles Schwab12,079,4430 00For
State Street5,952,4930 00For
Dimensional2,336,6420 00For
Franklin Custodian Funds2,053,7860 00For
TIAA1,833,2440 00For
Pacer Funds Trust1,570,9570 00For
JANUS INVESTMENT FUND1,389,6680 00For
Federated Hermes1,324,1540 00For
T. Rowe Price1,117,4570 00For
AMCAP FUND1,106,8840 00For
Jackson National1,105,9050 00For
Victory Capital1,039,5690 00For
INVESTMENT CO OF AMERICA990,2820 00For
ProShares980,7770 00For
Smead Funds Trust906,8630 00For
Invesco882,7380 00For
VanEck ETF Trust882,5070 00For
MASTER INVESTMENT PORTFOLIO774,6200 00For
CITY NATIONAL ROCHDALE FUNDS699,2800 00For
PRIMECAP Odyssey Funds618,1800 00For
Equitable609,9910 00For

Showing the 25 largest of 230 asset managers. All 230 are in the interactive database (link above).

Elect Director: Dr. S. Omar Ishrak

Official resultDIRECTOR ELECTIONSReported outcome: Elected

Combines 11 wordings of this item as funds reported it.

99% Majority: yes · of votes cast

FOR 99%
FOR: 398,671,821AGAINST: 5,218,699

Prior year: 99.1% for (May 31, 2024 meeting) ▼ 0.4 pts

Details: description as filed, official tally, votes by 230 asset managers

Description as filed by funds: To elect twelve directors to the Board of Directors of Amgen Inc. for a term of office expiring at the 2026 annual meeting of stockholders. The nominees for election to the Board of Directors are: Dr. S. Omar Ishrak

AMGEN INC.’s own tally for this item (“Elect Director: Dr. S. Omar Ishrak”): 398,671,821 for, 5,218,699 against, per its Form 8-K filed May 27, 2025 (Item 5.07). FOR was more than half of the votes cast. Whether the item passed is for the filing to say; its statement has not been read for this item.

Reported outcome: Elected, in the filing’s own words: “The final results of the voting for each matter submitted to a vote of stockholders at the meeting are as follows: Item 1 - Election of Directors Each of the following 12 nominees for director were elected to serve a one-year term expiring at the Company's 2026 annual meeting of stockholders and un…”
Support: 99% of votes cast — FOR ÷ (FOR + AGAINST); abstentions and broker non-votes are excluded.

The 230 asset managers below reported 178,900,228 for, 407,176 against, 27,737 abstained, 2,512 unknown.

FOR
FOR: 178,900,228AGAINST: 407,176ABSTAIN: 27,737UNKNOWN: 2,512
Largest asset managers voting on “To elect twelve directors to the Board of Directors of Amgen Inc. for a term of office expiring at the 2026 an” at AMGEN INC., 2024-2025
Asset managerForAgainst AbstainWithheldVote
Vanguard62,786,1297 10For
Capital Group33,518,1140 00For
BlackRock16,504,7890 00For
Fidelity13,803,2470 00For
Charles Schwab12,079,4430 00For
State Street5,952,4930 00For
Dimensional2,336,6420 00For
Franklin Custodian Funds2,053,7860 00For
TIAA1,833,2440 00For
Pacer Funds Trust1,570,9570 00For
JANUS INVESTMENT FUND1,389,6680 00For
Federated Hermes1,324,1540 00For
T. Rowe Price1,117,4570 00For
AMCAP FUND1,106,8840 00For
Jackson National1,105,9050 00For
Victory Capital1,039,5690 00For
INVESTMENT CO OF AMERICA990,2820 00For
ProShares980,7770 00For
Smead Funds Trust906,8630 00For
Invesco882,7380 00For
VanEck ETF Trust882,5070 00For
MASTER INVESTMENT PORTFOLIO774,6200 00For
CITY NATIONAL ROCHDALE FUNDS699,2800 00For
PRIMECAP Odyssey Funds618,1800 00For
Equitable609,9910 00For

Showing the 25 largest of 230 asset managers. All 230 are in the interactive database (link above).

Elect Director: Dr. Tyler Jacks

Official resultDIRECTOR ELECTIONSReported outcome: Elected

Combines 14 wordings of this item as funds reported it.

97% Majority: yes · of votes cast

FOR 97%
FOR: 392,818,616AGAINST: 10,591,022

Prior year: 97.3% for (May 31, 2024 meeting) unchanged

Details: description as filed, official tally, votes by 230 asset managers

Description as filed by funds: To elect twelve directors to the Board of Directors of Amgen Inc. for a term of office expiring at the 2026 annual meeting of stockholders. The nominees for election to the Board of Directors are: Dr. Tyler Jacks

AMGEN INC.’s own tally for this item (“Elect Director: Dr. Tyler Jacks”): 392,818,616 for, 10,591,022 against, per its Form 8-K filed May 27, 2025 (Item 5.07). FOR was more than half of the votes cast. Whether the item passed is for the filing to say; its statement has not been read for this item.

Reported outcome: Elected, in the filing’s own words: “The final results of the voting for each matter submitted to a vote of stockholders at the meeting are as follows: Item 1 - Election of Directors Each of the following 12 nominees for director were elected to serve a one-year term expiring at the Company's 2026 annual meeting of stockholders and un…”
Support: 97% of votes cast — FOR ÷ (FOR + AGAINST); abstentions and broker non-votes are excluded.

The 230 asset managers below reported 178,768,779 for, 538,590 against, 27,771 abstained, 2,512 unknown.

FOR
FOR: 178,768,779AGAINST: 538,590ABSTAIN: 27,771UNKNOWN: 2,512
Largest asset managers voting on “To elect twelve directors to the Board of Directors of Amgen Inc. for a term of office expiring at the 2026 an” at AMGEN INC., 2024-2025
Asset managerForAgainst AbstainWithheldVote
Vanguard62,786,11817 20For
Capital Group33,518,1140 00For
BlackRock16,501,2483,541 00For
Fidelity13,803,2470 00For
Charles Schwab12,079,4430 00For
State Street5,952,39895 00For
Dimensional2,336,6420 00For
Franklin Custodian Funds2,053,7860 00For
TIAA1,833,2440 00For
Pacer Funds Trust1,570,9570 00For
JANUS INVESTMENT FUND1,389,6680 00For
Federated Hermes1,324,1540 00For
T. Rowe Price1,117,4570 00For
AMCAP FUND1,106,8840 00For
Jackson National1,105,9050 00For
Victory Capital1,039,5690 00For
INVESTMENT CO OF AMERICA990,2820 00For
ProShares980,7770 00For
Smead Funds Trust906,8630 00For
Invesco882,7380 00For
VanEck ETF Trust882,5070 00For
MASTER INVESTMENT PORTFOLIO774,6200 00For
CITY NATIONAL ROCHDALE FUNDS699,2800 00For
PRIMECAP Odyssey Funds618,1800 00For
Equitable609,9910 00For

Showing the 25 largest of 230 asset managers. All 230 are in the interactive database (link above).

Elect Director: Dr. Mary E. Klotman

Official resultDIRECTOR ELECTIONSReported outcome: Elected

Combines 12 wordings of this item as funds reported it.

99.1% Majority: yes · of votes cast

FOR 99.1%
FOR: 400,133,252AGAINST: 3,547,127

Prior year: 99.7% for (May 31, 2024 meeting) ▼ 0.6 pts

Details: description as filed, official tally, votes by 230 asset managers

Description as filed by funds: To elect twelve directors to the Board of Directors of Amgen Inc. for a term of office expiring at the 2026 annual meeting of stockholders. The nominees for election to the Board of Directors are: Dr. Mary E. Klotman

AMGEN INC.’s own tally for this item (“Elect Director: Dr. Mary E. Klotman”): 400,133,252 for, 3,547,127 against, per its Form 8-K filed May 27, 2025 (Item 5.07). FOR was more than half of the votes cast. Whether the item passed is for the filing to say; its statement has not been read for this item.

Reported outcome: Elected, in the filing’s own words: “The final results of the voting for each matter submitted to a vote of stockholders at the meeting are as follows: Item 1 - Election of Directors Each of the following 12 nominees for director were elected to serve a one-year term expiring at the Company's 2026 annual meeting of stockholders and un…”
Support: 99.1% of votes cast — FOR ÷ (FOR + AGAINST); abstentions and broker non-votes are excluded.

The 230 asset managers below reported 179,271,910 for, 24,668 against, 40,073 abstained, 1,002 unknown.

FOR
FOR: 179,271,910AGAINST: 24,668ABSTAIN: 40,073UNKNOWN: 1,002
Largest asset managers voting on “To elect twelve directors to the Board of Directors of Amgen Inc. for a term of office expiring at the 2026 an” at AMGEN INC., 2024-2025
Asset managerForAgainst AbstainWithheldVote
Vanguard62,786,1296 10For
Capital Group33,518,1140 00For
BlackRock16,501,2483,541 00For
Fidelity13,803,2470 00For
Charles Schwab12,079,4430 00For
State Street5,952,4930 00For
Dimensional2,336,6420 00For
Franklin Custodian Funds2,053,7860 00For
TIAA1,833,2440 00For
Pacer Funds Trust1,570,9570 00For
JANUS INVESTMENT FUND1,389,6680 00For
Federated Hermes1,324,1540 00For
T. Rowe Price1,117,4570 00For
AMCAP FUND1,106,8840 00For
Jackson National1,105,9050 00For
Victory Capital1,039,5690 00For
INVESTMENT CO OF AMERICA990,2820 00For
ProShares980,7770 00For
Smead Funds Trust906,8630 00For
Invesco882,7380 00For
VanEck ETF Trust882,5070 00For
MASTER INVESTMENT PORTFOLIO774,6200 00For
CITY NATIONAL ROCHDALE FUNDS699,2800 00For
PRIMECAP Odyssey Funds618,1800 00For
Equitable609,9910 00For

Showing the 25 largest of 230 asset managers. All 230 are in the interactive database (link above).

Elect Director: Ms. Ellen J. Kullman

Official resultDIRECTOR ELECTIONSReported outcome: Elected

Combines 13 wordings of this item as funds reported it.

99% Majority: yes · of votes cast

FOR 99%
FOR: 399,256,857AGAINST: 4,429,859

Prior year: 97.9% for (May 31, 2024 meeting) ▲ 1.0 pts

Details: description as filed, official tally, votes by 230 asset managers

Description as filed by funds: To elect twelve directors to the Board of Directors of Amgen Inc. for a term of office expiring at the 2026 annual meeting of stockholders. The nominees for election to the Board of Directors are: Ms. Ellen J. Kullman

AMGEN INC.’s own tally for this item (“Elect Director: Ms. Ellen J. Kullman”): 399,256,857 for, 4,429,859 against, per its Form 8-K filed May 27, 2025 (Item 5.07). FOR was more than half of the votes cast. Whether the item passed is for the filing to say; its statement has not been read for this item.

Reported outcome: Elected, in the filing’s own words: “The final results of the voting for each matter submitted to a vote of stockholders at the meeting are as follows: Item 1 - Election of Directors Each of the following 12 nominees for director were elected to serve a one-year term expiring at the Company's 2026 annual meeting of stockholders and un…”
Support: 99% of votes cast — FOR ÷ (FOR + AGAINST); abstentions and broker non-votes are excluded.

The 230 asset managers below reported 179,039,563 for, 269,336 against, 27,752 abstained, 1,002 unknown.

FOR
FOR: 179,039,563AGAINST: 269,336ABSTAIN: 27,752UNKNOWN: 1,002
Largest asset managers voting on “To elect twelve directors to the Board of Directors of Amgen Inc. for a term of office expiring at the 2026 an” at AMGEN INC., 2024-2025
Asset managerForAgainst AbstainWithheldVote
Vanguard62,786,1288 10For
Capital Group33,518,1140 00For
BlackRock16,501,2483,541 00For
Fidelity13,803,2470 00For
Charles Schwab12,079,4430 00For
State Street5,952,4930 00For
Dimensional2,336,6420 00For
Franklin Custodian Funds2,053,7860 00For
TIAA1,833,2440 00For
Pacer Funds Trust1,570,9570 00For
JANUS INVESTMENT FUND1,389,6680 00For
Federated Hermes1,324,1540 00For
T. Rowe Price1,117,4570 00For
AMCAP FUND1,106,8840 00For
Jackson National1,105,9050 00For
Victory Capital1,039,5690 00For
INVESTMENT CO OF AMERICA990,2820 00For
ProShares980,7770 00For
Smead Funds Trust906,8630 00For
Invesco882,7380 00For
VanEck ETF Trust882,5070 00For
MASTER INVESTMENT PORTFOLIO774,6200 00For
CITY NATIONAL ROCHDALE FUNDS699,2800 00For
PRIMECAP Odyssey Funds618,1800 00For
Equitable609,9910 00For

Showing the 25 largest of 230 asset managers. All 230 are in the interactive database (link above).

Elect Director: Ms. Amy E. Miles

Official resultDIRECTOR ELECTIONSReported outcome: Elected

Combines 12 wordings of this item as funds reported it.

99% Majority: yes · of votes cast

FOR 99%
FOR: 399,556,351AGAINST: 4,116,751

Prior year: 97.2% for (May 31, 2024 meeting) ▲ 1.7 pts

Details: description as filed, official tally, votes by 230 asset managers

Description as filed by funds: To elect twelve directors to the Board of Directors of Amgen Inc. for a term of office expiring at the 2026 annual meeting of stockholders. The nominees for election to the Board of Directors are: Ms. Amy E. Miles

AMGEN INC.’s own tally for this item (“Elect Director: Ms. Amy E. Miles”): 399,556,351 for, 4,116,751 against, per its Form 8-K filed May 27, 2025 (Item 5.07). FOR was more than half of the votes cast. Whether the item passed is for the filing to say; its statement has not been read for this item.

Reported outcome: Elected, in the filing’s own words: “The final results of the voting for each matter submitted to a vote of stockholders at the meeting are as follows: Item 1 - Election of Directors Each of the following 12 nominees for director were elected to serve a one-year term expiring at the Company's 2026 annual meeting of stockholders and un…”
Support: 99% of votes cast — FOR ÷ (FOR + AGAINST); abstentions and broker non-votes are excluded.

The 230 asset managers below reported 179,042,351 for, 266,548 against, 27,753 abstained, 1,002 unknown.

FOR
FOR: 179,042,351AGAINST: 266,548ABSTAIN: 27,753UNKNOWN: 1,002
Largest asset managers voting on “To elect twelve directors to the Board of Directors of Amgen Inc. for a term of office expiring at the 2026 an” at AMGEN INC., 2024-2025
Asset managerForAgainst AbstainWithheldVote
Vanguard62,786,1287 10For
Capital Group33,518,1140 00For
BlackRock16,504,7890 00For
Fidelity13,803,2470 00For
Charles Schwab12,079,4430 00For
State Street5,952,4930 00For
Dimensional2,336,6420 00For
Franklin Custodian Funds2,053,7860 00For
TIAA1,833,2440 00For
Pacer Funds Trust1,570,9570 00For
JANUS INVESTMENT FUND1,389,6680 00For
Federated Hermes1,324,1540 00For
T. Rowe Price1,117,4570 00For
AMCAP FUND1,106,8840 00For
Jackson National1,105,9050 00For
Victory Capital1,039,5690 00For
INVESTMENT CO OF AMERICA990,2820 00For
ProShares980,7770 00For
Smead Funds Trust906,8630 00For
Invesco882,7380 00For
VanEck ETF Trust882,5070 00For
MASTER INVESTMENT PORTFOLIO774,6200 00For
CITY NATIONAL ROCHDALE FUNDS699,2800 00For
PRIMECAP Odyssey Funds618,1800 00For
Equitable609,9910 00For

Showing the 25 largest of 230 asset managers. All 230 are in the interactive database (link above).

Advisor y Vote to A pprove Our Executive Compensation The advisory vote to approve our executive compensation

Official resultFund totals may overlapSECTION 14A SAY-ON-PAY VOTESReported outcome: Approved

Combines 27 wordings of this item as funds reported it.

95% Approved · of votes cast

FOR 95%
FOR: 381,269,281AGAINST: 21,382,050

Prior year: 93.8% for (May 31, 2024 meeting) ▲ 0.9 pts

Details: description as filed, official tally, votes by 1,448 asset managers

Description as filed by funds: Advisory vote to approve our executive compensation.

AMGEN INC.’s own tally for this item (“2. Advisor y Vote to A pprove Our Executive Compensation The advisory vote to approve our executive compensation”): 381,269,281 for, 21,382,050 against — passed, per its Form 8-K filed May 27, 2025 (Item 5.07).

Reported outcome: Approved, in the filing’s own words: “Item 2 - Advisor y Vote to A pprove Our Executive Compensation The advisory vote to approve our executive compensation was approved.”
Support: 95% of votes cast — FOR ÷ (FOR + AGAINST); abstentions and broker non-votes are excluded.

Also reported under other wordings, matched to the same row of AMGEN INC.’s official tally and shown with their own fund figures; their managers are not in the figures or the table on this card: “Advisory Vote to Ratify Named Executive Officers' Compensation” (58 managers, Fund and manager reports combined; may count the same shares twice; no share total shown); “SECTION 14A SAY-ON-PAY VOTES” (3 managers, 28,133 for); “COMPENSATION” (2 managers, 4,247 for).

Fund voting reports and institutional-manager reports both cover this item. An institutional manager can report shares that a fund it advises also reports, so the two are shown separately below and never added together, and their sum is not shown (fund and manager reports combined may count the same shares twice).

Fund voting reports: 208 asset managers voting on “Advisory vote to approve our executive compensation.” at AMGEN INC., 2024-2025
Asset managerForAgainst AbstainWithheldVote
Vanguard62,769,12017,014 30For
Capital Group33,518,1140 00For
BlackRock16,495,8138,976 00For
Fidelity13,803,2470 00For
Charles Schwab12,079,4430 00For
State Street5,910,38642,107 00For
Dimensional2,336,6420 00For
Franklin Custodian Funds2,053,7860 00For
TIAA1,833,2440 00For
Pacer Funds Trust1,570,9570 00For
JANUS INVESTMENT FUND1,389,6680 00For
Federated Hermes1,324,1540 00For
T. Rowe Price1,117,4570 00For
AMCAP FUND1,106,8840 00For
Jackson National1,105,9050 00For
Victory Capital1,039,5690 00For
INVESTMENT CO OF AMERICA990,2820 00For
ProShares980,7770 00For
Smead Funds Trust906,8630 00For
Invesco882,7380 00For
VanEck ETF Trust882,5070 00For
MASTER INVESTMENT PORTFOLIO774,6200 00For
CITY NATIONAL ROCHDALE FUNDS699,2800 00For
PRIMECAP Odyssey Funds618,1800 00For
Equitable609,9910 00For

Fund voting reports, all 208 managers: 177,380,237 for, 1,175,067 against, 2,151 withheld, 42,820 abstained. Showing the 25 largest; every one is in the interactive database (link above).

Institutional-manager reports: 1,269 asset managers voting on “Advisory vote to approve our executive compensation.” at AMGEN INC., 2024-2025
Asset managerForAgainst AbstainWithheldVote
Capital Group32,099,5217,175 00For
BlackRock19,525,61510,324 00For
State Street14,376,47142,107 00For
GEODE CAPITAL MANAGEMENT, LLC12,644,9520 00For
PRIMECAP MANAGEMENT CO/CA/12,201,6500 00For
Charles Schwab12,153,1120 00For
Northern Trust5,177,7640 00For
Capital Research Global Investors4,534,2330 00For
Vanguard3,572,9120 00For
Aristotle Capital Management, LLC3,477,8750 00For
FRANKLIN ADVISERS INC3,079,5780 00For
MELLON INVESTMENTS Corp3,074,1790 00For
Fidelity3,023,8500 00For
Invesco2,985,3860 00For
STATE FARM MUTUAL AUTOMOBILE INSURANCE CO2,715,6560 00For
T. Rowe Price2,685,63921,720 00For
RBC Capital Markets, LLC2,567,2060 00For
UBS2,453,04751,415 00For
Janus Henderson2,472,4160 00For
PARAMETRIC PORTFOLIO ASSOCIATES LLC2,424,5400 00For
Legal & General Investment Management Ltd58,7792,176,495 00Against
Nuveen2,090,5740 00For
Federated Hermes1,935,6360 00For
Amundi01,767,026 00Against
Sumitomo Mitsui Trust Asset Management Co., Ltd.1,429,9830 00For

Institutional-manager reports, all 1,269 managers: 208,751,927 for, 12,411,829 against, 20,913 abstained, 63,571 not voted, 23,203 unknown. Showing the 25 largest; every one is in the interactive database (link above).

Ratification of Selection of Inde pendent Re gistered Public Accountants Ernst & Young LLP

Official resultAUDIT-RELATEDReported outcome: Approved

Combines 7 wordings of this item as funds reported it.

94% Approved · of votes cast

FOR 94%
FOR: 441,615,581AGAINST: 26,675,877

Prior year: 93.8% for (May 31, 2024 meeting) ▲ 0.5 pts

Details: description as filed, official tally, votes by 230 asset managers

Description as filed by funds: To ratify the selection of Ernst & Young LLP as our independent registered public accountants for the fiscal year ending December 31, 2025.

AMGEN INC.’s own tally for this item (“3. Ratification of Selection of Inde pendent Re gistered Public Accountants Ernst & Young LLP”): 441,615,581 for, 26,675,877 against — passed, per its Form 8-K filed May 27, 2025 (Item 5.07).

Reported outcome: Approved, in the filing’s own words: “Item 3 - Ratification of Selection of Inde pendent Re gistered Public Accountants Ernst & Young LLP was ratified as the Company's independent registered public accountants for the fiscal year ending December 31, 2025.”
Support: 94% of votes cast — FOR ÷ (FOR + AGAINST); abstentions and broker non-votes are excluded.

Also reported under other wordings, matched to the same row of AMGEN INC.’s official tally and shown with their own fund figures; their managers are not in the figures or the table on this card: “Ratify Appointment of Independent Auditors” (9 managers, 39,899 for, 232,997 against).

The 230 asset managers below reported 177,871,751 for, 1,182,682 against, 27,728 abstained, 1,510 unknown.

FOR
FOR: 177,871,751AGAINST: 1,182,682ABSTAIN: 27,728UNKNOWN: 1,510
Largest asset managers voting on “To ratify the selection of Ernst & Young LLP as our independent registered public accountants for the fiscal y” at AMGEN INC., 2024-2025
Asset managerForAgainst AbstainWithheldVote
Vanguard62,766,83519,301 10For
Capital Group33,518,1140 00For
BlackRock16,504,7890 00For
Fidelity13,803,2470 00For
Charles Schwab12,079,4430 00For
State Street5,952,39895 00For
Dimensional2,336,6420 00For
Franklin Custodian Funds2,053,7860 00For
TIAA1,833,2440 00For
Pacer Funds Trust1,570,9570 00For
JANUS INVESTMENT FUND1,389,6680 00For
Federated Hermes1,324,1540 00For
T. Rowe Price1,117,4570 00For
AMCAP FUND1,106,8840 00For
Jackson National1,105,9050 00For
Victory Capital1,039,5690 00For
INVESTMENT CO OF AMERICA990,2820 00For
ProShares980,7770 00For
Smead Funds Trust906,8630 00For
Invesco882,7380 00For
VanEck ETF Trust882,5070 00For
MASTER INVESTMENT PORTFOLIO774,6200 00For
CITY NATIONAL ROCHDALE FUNDS699,2800 00For
PRIMECAP Odyssey Funds618,1800 00For
Equitable609,9910 00For

Showing the 25 largest of 230 asset managers. All 230 are in the interactive database (link above).

Not shown here: this season’s fund filings also report 1 item from the meeting of May 31, 2024, which belongs to the 2023-2024 season. A meeting outside this season’s July 1 to June 30 window is not counted in this page’s items or in its totals of asset managers and fund votes.

Largest AMGEN INC. shareholders voting in 2024-2025

Ranked separately for each type of Form N-PX report. An institutional manager can report shares that a fund it advises also reports, so the two tables can list the same shares and are never added together. Each is ranked by the shares voted on the item that the most managers of that type reported, shown as a share of the 537,700,000 shares outstanding at the time of that meeting.

Fund voting reports: top AMGEN INC. shareholders by shares voted on “To elect twelve directors to the Board of Directors of Amgen Inc. for a term of office expiring…”, 2024-2025
#Asset manager % of shares outstanding
1Vanguard 11.68%
2Capital Group 6.23%
3BlackRock 3.07%
4Fidelity 2.57%
5Charles Schwab 2.25%
6State Street 1.11%
7Dimensional 0.43%
8Franklin Custodian Funds 0.38%
9TIAA 0.34%
10Pacer Funds Trust 0.29%
Institutional-manager reports: top AMGEN INC. shareholders by shares voted on “Advisory vote to approve our executive compensation.”, 2024-2025
#Asset manager % of shares outstanding
1Capital Group 5.97%
2BlackRock 3.63%
3State Street 2.68%
4GEODE CAPITAL MANAGEMENT, LLC 2.35%
5PRIMECAP MANAGEMENT CO/CA/ 2.27%
6Charles Schwab 2.27%
7Northern Trust 0.96%
8Capital Research Global Investors 0.84%
9Vanguard 0.66%
10Aristotle Capital Management, LLC 0.65%

Reported AMGEN INC. holdings and ownership

As disclosed to the SEC in Form 13F (quarter-end holdings of 30 large managers), Schedules 13D and 13G (beneficial ownership above 5%) and the company’s own proxy statement (DEF 14A). Each row gives its source and the date its figure is as of: for Form 13F the quarter end it reports, for Schedules 13D and 13G the filing date, and for the proxy statement the date of its ownership table (or, where that date has not been read, the date the proxy was filed). The rows are therefore not all as of the same day.

AMGEN INC. holdings and ownership disclosed for the 2024-2025 proxy season, with each row’s source and date
HolderShares % outstandingSource, as of
Vanguard Group52,870,453 9.83%Form 13F, quarter ended March 31, 2025
BlackRock45,439,431 8.45%Form 13F, quarter ended March 31, 2025
State Street29,179,991 5.43%Form 13F, quarter ended March 31, 2025
Morgan Stanley16,234,121 3.02%Form 13F, quarter ended March 31, 2025
Geode Capital12,727,346 2.37%Form 13F, quarter ended March 31, 2025
Charles Schwab12,205,942 2.27%Form 13F, quarter ended March 31, 2025
Northern Trust6,206,067 1.15%Form 13F, quarter ended March 31, 2025
Norges Bank5,641,524 1.05%Form 13F, quarter ended March 31, 2025
Goldman Sachs4,454,164 0.83%Form 13F, quarter ended March 31, 2025

Percentages above are of 537,700,000 shares outstanding, as reported by AMGEN INC. on its Form 10-Q dated March 31, 2025 (see the filing on EDGAR). This is the count contemporaneous with the 2024-2025 meeting, not today’s. Each holding is as of its own filing, which may be dated before or after the meeting.

About this meeting

At AMGEN INC.'s shareholder meeting held May 23, 2025, in the 2024-2025 proxy season, 1,504 asset managers reported votes on at least one of its 14 ballot items in their SEC Form N-PX filings, covering 18,076 separate fund positions. On the most widely held item on that ballot — Advisory vote to approve our executive compensation. — AMGEN INC.'s filing reports the proposal as approved, with 95% support of the votes cast (FOR divided by FOR plus AGAINST, the conventional basis for proxy support; abstentions, broker non-votes and unvoted shares are excluded because none of them took a side). Source: AMGEN INC.'s Form 8-K, Item 5.07, filed with the U.S. Securities and Exchange Commission on May 27, 2025.

Related

About this page

Every figure above is derived from filings made with the US Securities and Exchange Commission: Form N-PX, in which registered funds disclose how they voted every proxy and institutional managers disclose their votes on executive pay (say-on-pay, say-on-frequency and golden parachutes), and Form 8-K Item 5.07, in which the company reports its own meeting results. Shares outstanding are taken from AMGEN INC.’s 10-Q dated March 31, 2025. This page is a static snapshot rebuilt weekly on November 20, 2026; a live search always shows the current data.

AMGEN INC. proxy season coverage: 2023-2024 · 2024-2025 (this page) · 2025-2026.

Cite this page

Proxy Votes Now, “AMGEN (AMGN) 2025 Annual Meeting: Vote Results & How Funds Voted”, https://proxyvotesnow.com/company/amgen-inc/2025 (version of November 20, 2026). Derived from SEC Form N-PX and Form 8-K filings; tables licensed CC BY 4.0. Licence: CC BY 4.0.